Bingchen Wu

Dr. Bingchen Wu

University of Pittsburgh
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Biomaterials
Verified
Journal Article
Closed access
AGAsiyeh Golabchi
Asiyeh Golabchi
BWBingchen Wu
Bingchen Wu
BCBin Cao
Bin Cao
CBChristopher J. Bettinger
Christopher J. Bettinger
XCXinyan Cui
Xinyan Cui

1 October 2018 in Biomaterials
Verified
Journal Article
Closed access
AGAsiyeh Golabchi
Asiyeh Golabchi
BWBingchen Wu
Bingchen Wu
XLXia Li
Xia Li
DCDiane L. Carlisle
Diane L. Carlisle
TKTakashi D.Y. Kozai
Takashi D.Y. Kozai
XCXinyan Cui
Xinyan Cui

21 March 2023 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
ECElisa Castagnola
Elisa Castagnola
ERElaine Marie Robbins
Elaine Marie Robbins
DKDaniela D. Krahe
Daniela D. Krahe
BWBingchen Wu
Bingchen Wu
MPMay Yoon Pwint
May Yoon Pwint
XCXinyan Cui
Xinyan Cui

18 February 2021 in Micromachines
Verified
Journal Article
Open access
PDF file
CTCHAO TAN
CHAO TAN
ERElaine Marie Robbins
Elaine Marie Robbins
BWBingchen Wu
Bingchen Wu
XCXinyan Cui
Xinyan Cui
The brain is a complex network that accounts for only 5% of human mass but consumes 20% of our energy. Uncovering the mysteries of the brain’s functions in motion, memory, learning, behavior, and mental health remains a hot but challenging topic. Neurochemicals in the brain, such as neurotransmitters, neuromodulators, gliotransmitters, hormones, and metabolism substrates and products, play vital roles in mediating and modulating normal brain function, and their abnormal release or imbalanced concentrations can cause various diseases, such as epilepsy, Alzheimer’s disease, and Parkinson’s disease. A wide range of techniques have been used to probe the concentrations of neurochemicals under normal, stimulated, diseased, and drug-induced conditions in order to understand the neurochemistry of drug mechanisms and develop diagnostic tools or therapies. Recent advancements in detection methods, device fabrication, and new materials have resulted in the development of neurochemical sensors with improved performance. However, direct in vivo measurements require a robust sensor that is highly sensitive and selective with minimal fouling and reduced inflammatory foreign body responses. Here, we review recent advances in neurochemical sensor development for in vivo studies, with a focus on electrochemical and optical probes. Other alternative methods are also compared. We discuss in detail the in vivo challenges for these methods and provide an outlook for future directions.

27 June 2024 in Microsystems & Nanoengineering
Verified
Journal Article
Open access
PDF file
MMMohammad Hassan Malekoshoaraie
Mohammad Hassan Malekoshoaraie
BWBingchen Wu
Bingchen Wu
DKDaniela D. Krahe
Daniela D. Krahe
ZAZabir Ahmed
Zabir Ahmed
SPStephen Pupa
Stephen Pupa
MCMaysamreza Chamanzar
Maysamreza Chamanzar
Targeted delivery of neurochemicals and biomolecules for neuromodulation of brain activity is a powerful technique that, in addition to electrical recording and stimulation, enables a more thorough investigation of neural circuit dynamics. We have designed a novel, flexible, implantable neural probe capable of controlled, localized chemical stimulation and electrophysiology recording. The neural probe was implemented using planar micromachining processes on Parylene C, a mechanically flexible, biocompatible substrate. The probe shank features two large microelectrodes (chemical sites) for drug loading and sixteen small microelectrodes for electrophysiology recording to monitor neuronal response to drug release. To reduce the impedance while keeping the size of the microelectrodes small, poly(3,4-ethylenedioxythiophene) (PEDOT) was electrochemically coated on recording microelectrodes. In addition, PEDOT doped with mesoporous sulfonated silica nanoparticles (SNPs) was used on chemical sites to achieve controlled, electrically-actuated drug loading and releasing. Different neurotransmitters, including glutamate (Glu) and gamma-aminobutyric acid (GABA), were incorporated into the SNPs and electrically triggered to release repeatedly. An in vitro experiment was conducted to quantify the stimulated release profile by applying a sinusoidal voltage (0.5 V, 2 Hz). The flexible neural probe was implanted in the barrel cortex of the wild-type Sprague Dawley rats. As expected, due to their excitatory and inhibitory effects, Glu and GABA release caused a significant increase and decrease in neural activity, respectively, which was recorded by the recording microelectrodes. This novel flexible neural probe technology, combining on-demand chemical release and high-resolution electrophysiology recording, is an important addition to the neuroscience toolset used to dissect neural circuitry and investigate neural network connectivity.

4 May 2020 in Advanced Biosystems
Verified
Journal Article
Closed access
PDF file
QYQianru Yang
Qianru Yang
BWBingchen Wu
Bingchen Wu
JEJames R. Eles
James R. Eles
AVAlberto L. Vazquez
Alberto L. Vazquez
TKTakashi D. Y. Kozai
Takashi D. Y. Kozai
XCXinyan Cui
Xinyan Cui